News

• March 30, 2023
  Targovax ASA: Requested Conversion of Convertible Bonds
• March 15, 2023
  Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting
• March 14, 2023
  Targovax: First patient dosed with TG01 in the USA
• March 9, 2023
  Targovax ASA – First Tranche of Convertible Bonds

All news

Company presentations

• Company presentation January 2023

Events

• April 13, 2023 Annual Report Add to Calendar
• April 14 - April 19, 2023 American Association for Cancer Research (AACR) Orlando Add to Calendar
• April 20, 2023 Annual General Meeting 2023 Add to Calendar

All events

Mesothelioma 30-month data

The 30-month data from the mesothelioma trial was released December 2021. See press release here.
For a video presentation of the 24-month data from June 2021, please see links below:

• English
• Norwegian

Q4 Fourth Quarter 2022

Targovax announced its fourth quarter 2022 results on Thursday 16 February 2023.

Webcast: 10:00 a.m. CET the same day

• Report
• Presentation
• Webcast

Read the report

Webcast presentation on Xtrainvestor

For a company presentation in Norwegian, please see video below.

• Webcast

Share price